Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...
The Company signed a non-binding MOU agreement with Arrow Aviation, a lucrative high- growth company with annual unaudited ...
You may owe net investment income tax if you made more than the NIIT income threshold. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you ...
OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the signing of a non-binding ...
Ovarian cancer is characterized by uncontrolled growth of cells in the ovaries. It can progress to another part of the body ...
AIA launches AIA Voluntary Health Insurance SelectWise Scheme Elevating in-patient care at designated hospitals[1] ...
New study reveals a central role of selenoprotein GPX3 in attenuating acute kidney injury Renal ischemia–reperfusion injury ...
The study on Influenza D and Canine Coronavirus HuPn-2018 underscores urgent needs for targeted surveillance and diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results